Second-Line Treatment for AOM After Augmentin Failure
For children with acute otitis media who fail amoxicillin-clavulanate (Augmentin) treatment after 48-72 hours, the recommended second-line therapy is intramuscular ceftriaxone 50 mg/kg for 3 days. 1
Treatment Algorithm After Augmentin Failure
Step 1: Confirm Treatment Failure (48-72 Hours)
Treatment failure is defined as:
- Persistent or worsening fever (≥39°C)
- Continued or worsening otalgia
- No improvement in otologic findings on examination
- Persistent irritability, poor sleep, or feeding difficulties
Important caveat: Some children may have combined bacterial-viral infection, with middle ear fluid being sterile in 42-49% of cases with persistent symptoms. 1 However, 86-91% of cases with persistent symptoms do have continued bacterial presence, so antibiotic change is warranted for severe symptoms. 1
Step 2: Second-Line Treatment - Ceftriaxone
Intramuscular ceftriaxone 50 mg/kg daily for 3 days is the guideline-recommended choice. 1
- A 3-day course is superior to a 1-day regimen for treatment-unresponsive AOM 1
- This provides coverage for resistant Streptococcus pneumoniae, β-lactamase-producing Haemophilus influenzae, and Moraxella catarrhalis
- Particularly effective when the child has already received oral antibiotics recently
Step 3: If Ceftriaxone Fails - Third-Line Options
If the patient fails ceftriaxone (or if ceftriaxone is not feasible), consider:
Clindamycin 30-40 mg/kg/day in 3 divided doses PLUS a third-generation cephalosporin (cefdinir, cefixime, or cefuroxime) 1
- Clindamycin covers resistant S. pneumoniae but does NOT cover H. influenzae or M. catarrhalis
- Must combine with a cephalosporin for complete coverage
- Critical limitation: Serotype 19A S. pneumoniae is often multidrug-resistant and may not respond to clindamycin 1
Step 4: Multiple Treatment Failures - Tympanocentesis
When multiple antibiotics have failed, tympanocentesis with culture and susceptibility testing becomes essential to guide further therapy. 1
After tympanocentesis, if multidrug-resistant bacteria are identified:
- Consider levofloxacin (not FDA-approved for children, quinolone concerns)
- Consider linezolid (effective against resistant Gram-positive bacteria, not FDA-approved for AOM, expensive)
- Consult pediatric infectious disease and otolaryngology before using these unconventional agents 1
What NOT to Use After Augmentin Failure
Avoid trimethoprim-sulfamethoxazole and erythromycin-sulfisoxazole - pneumococcal resistance to these agents is substantial, making them inappropriate for treatment failures. 1
Key Clinical Pitfalls
Don't change antibiotics for mild persistent symptoms - some children with mild ongoing symptoms may have viral co-infection and don't require antibiotic change 1
Assess severity before switching - only children with persistent SEVERE symptoms and unimproved otologic findings warrant antibiotic change 1
Recent antibiotic exposure matters - if the child received amoxicillin in the previous 30 days before starting Augmentin, resistance is more likely and aggressive second-line therapy is justified 1
Age considerations - children under 2 years and those in daycare have higher rates of resistant organisms 2
Evidence Quality Note
The 2013 American Academy of Pediatrics guideline 1 provides the most authoritative and detailed treatment algorithm for Augmentin failures. The 2017 guideline 3 focused more on initial treatment choices rather than treatment failures. The FDA label for Augmentin ES-600 2 confirms its efficacy but doesn't address failure management. Recent research 4, 5 shows that treatment failure with amoxicillin-based regimens is uncommon (2-5%), supporting the guideline approach of reserving aggressive therapy for true failures.